Drug & supplement interaction

Expressive Therapies + Pemigatinib

Pemigatinib brand name: Pemazyre.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Expressive Therapies and Pemigatinib in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone interested in this? Share
Interaction report

Expressive Therapies and Pemigatinib

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Pemigatinib and Expressive Therapies in our sources. This does not guarantee that the combination is completely free of risk — research on Expressive Therapies alongside specific medications may be limited.

Worth understanding: our licensed dataset holds no drug-interaction record for Expressive Therapies at all — not against Pemigatinib, and not against any other medication we track. This verdict therefore rests on the absence of any recorded data, not on research that looked at this combination and found nothing. We cannot rule an interaction out.

Expressive Therapies is a treatment rather than something you take. Tell whoever provides it which medicines you use, and ask your prescriber whether it is appropriate for your health and treatment. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Expressive Therapies safety at a glance

Expressive Therapi... overall Generally safe Generally considered safe and low-risk when guided by a trained therapist.
Pregnancy Generally safe Non-drug creative therapies are generally safe during pregnancy.
Breastfeeding Generally safe Non-drug creative therapies are generally safe while breastfeeding.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Pemigatinib and Expressive Therapies? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
What to actually watch for

What Pemigatinib’s Own FDA Label Lists

This is not an interaction — none of it involves Expressive Therapies. These are the most notable effects listed in the ADVERSE REACTIONS section of Pemigatinib’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you have Expressive Therapies and take the medicine. 10 of them are worth acting on rather than waiting out — marked below.

  • A bowel blockage Worth acting on
  • Dehydration Worth acting on
  • Low sodium Worth acting on
  • Yellowing of the skin or eyes Worth acting on
  • Heart failure Worth acting on
  • Fainting Worth acting on
  • An irregular heartbeat Worth acting on
  • A low platelet count Worth acting on
  • Kidney problems Worth acting on
  • Anemia Worth acting on

Showing the 10 most notable of 40 label-listed effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

From the ADVERSE REACTIONS section of the FDA label for Pemigatinib. Read the label on DailyMed › Where a percentage is shown, it is the share of 788 voluntary FDA FAERS reports for Pemigatinib that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Expressive Therapies’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no Expressive Therapies side to compare — that is a limit of the record, not a statement that Expressive Therapies has no side effects.

Everything else you take

See Every Supplement That Interacts With Pemigatinib

This page covers Expressive Therapies only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Pemigatinib page lists 138 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), Grapefruit (major), St. John's Wort (major), Acacia Rigidula (moderate) and Adrafinil (moderate).

By severity: 3 major · 94 moderate · 41 minor.

From our pharmacist’s overview on the Pemigatinib page

“Pemigatinib (Pemazyre) is a targeted therapy for bile duct cancer, and it only works if its blood level stays where it should. Of the 138 supplements and herbs on file, 121 affect the liver enzyme (CYP3A4) that clears pemigatinib, which can push levels up toward worse side effects or pull them down until the cancer goes undertreated.”

Reviewed by 2 · Jul 18, 2026

Open the Pemigatinib interaction page

How much people look this up

Where Expressive Therapies and Pemigatinib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Expressive Therapies
Steady interest

#1,337 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Pemigatinib
Top half

#1,347 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions. Expressive Therapies is not yet covered by that licensed database, so its write-up cites publicly available medical sources directly (see the references below).
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Expressive Therapies reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Expressive Therapies and Pemigatinib records this page draws on were last updated June 20, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Treatment approach

About Expressive Therapies

What is Expressive Therapies?

  • Anxiety and stress
  • Depression and low mood
  • Coping with trauma or grief
  • Emotional expression and self-awareness
  • Support during serious illness or rehabilitation

Expressive therapies are mind-body treatments that use creative activities like art, music, dance, drama, or writing to help people process emotions and improve mental well-being. They are not a supplement, herb, or medicine you take. They are generally low-risk and are usually used alongside, not instead of, standard medical or mental health care.

Not applicable — this is a mind-body therapy, not a plant or supplement · Art therapy, music therapy, dance/movement therapy, drama therapy, writing/poetry therapy

An interaction check asks whether these two react with each other — it does not ask whether Expressive Therapies is a good idea for someone in your situation. Here is what our Expressive Therapies record says about it on its own.

Expressive Therapies: dosing

There is no standard "dose" for expressive therapies because they are activities, not products. How often and how long sessions last can vary widely depending on the type of therapy, the program, and your goals.Sessions are often offered weekly, in either one-on-one or group settings, and may run for several weeks or longer. Look for therapists who are licensed or certified in their specific field, such as a board-certified music therapist or registered art therapist.

From our Expressive Therapies monograph — the full record covers uses, side effects and every documented interaction.

Read the full Expressive Therapies monograph & all interactions
Medication

About Pemigatinib

What Is Pemigatinib Used For?

Brand name: Pemazyre

Pemazyre (pemigatinib) is used to treat adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma (bile duct cancer) whose tumors have a specific genetic change called an FGFR2 fusion or rearrangement, confirmed by an FDA-approved test. This approval is based on tumor response rates; continued approval may depend on results from further confirmatory studies.

Pemazyre is also approved to treat adults with relapsed or refractory myeloid/lymphoid neoplasms (MLNs) — certain blood and bone marrow cancers — that carry an FGFR1 rearrangement and have come back or stopped responding to prior treatment.

Most-Reported Side Effects for Pemigatinib

From FAERS, the FDA’s public side-effect reporting system (821 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Disease progression 140 reports
Fatigue 79 reports
Alopecia 63 reports
Cholangiocarcinoma 60 reports
Hyperphosphataemia 51 reports
See full Pemigatinib drug information
Keep checking

Other Drugs & Expressive Therapies

Browse every other medication we’ve checked against Expressive Therapies — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
0Moderate
0Minor
2,829No known interaction
No interaction 2,829 drugs checked — show the list
Evidence & sources

Expressive Therapies References

The 1 sources that drive our Expressive Therapies monograph — publicly available pages from reputable medical and government organizations. Every link was verified to work before publishing. Expressive Therapies is not covered by the licensed Natural Medicines interaction database, so its page cites these public sources directly.

  1. Complementary, Alternative, or Integrative Health: What's In a Name? — NIH NCCIH Source

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Having Expressive Therapies While Taking Pemigatinib: Common Questions

Is it safe to have Expressive Therapies while taking Pemigatinib?
We do not list a known interaction between Expressive Therapies and Pemigatinib. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Does Pemigatinib interact with any supplements?
Yes. Pemigatinib has documented interactions with 138 supplements in our database — Expressive Therapies is not one of them. The Pemigatinib interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Pemigatinib and Expressive Therapies?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.